They do mean thyroid tests may not be static once treatment begins
It wasn't just about eating less
By lowering inflammation, semaglutide may indirectly reduce the stimulus for sustained cortisol elevation, creating a favorable metabolic feedback loop
[2] However, findings suggest that the majority of individuals that start a GLP-1 do not take the medication for the recommended 12 weeks, suggesting they are not achieving clinically meaningful weight loss.[2] Currently, 1 in 8 American adults have used one of the GLP-1 drugs and at least 30% ceased before 4 weeks, likely due to gastrointestinal distress.[2] Additionally, it is reported that there were over 25,000 emergency room visits between 2022-2023 due to GLP-1 use
This observation has prompted scientists to consider increased food consumption as a potential contributor to the weight gain noted in research models exposed to Ipamorelin
Actual product packaging and materials may contain more and/or different information than shown on our website
